BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

18 related articles for article (PubMed ID: 38554673)

  • 1. Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Mehra R; Nallandhighal S; Cotta B; Knuth Z; Su F; Kasputis A; Zhang Y; Wang R; Cao X; Udager AM; Dhanasekaran SM; Cieslik MP; Morgan TM; Salami SS
    JCO Precis Oncol; 2024 May; 8():e2300565. PubMed ID: 38810179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Profile of Important Genes for Radiogenomics in the Amazon Indigenous Population.
    de Lima MC; de Castro CC; Aguiar KEC; Monte N; Nunes GGDC; Costa ACAD; Rodrigues JCG; Guerreiro JF; Ribeiro-Dos-Santos Â; Assumpção PP; Burbano RMR; Fernandes MR; Dos Santos SEB; Dos Santos NPC
    J Pers Med; 2024 Apr; 14(5):. PubMed ID: 38793065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma.
    Gao J; Ye F; Han F; Wang X; Jiang H; Zhang J
    Front Oncol; 2021; 11():739815. PubMed ID: 34692518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-Enhanced Computed Tomography-Based Radiogenomics Analysis for Predicting Prognosis in Gastric Cancer.
    Liu H; Wang Y; Liu Y; Lin D; Zhang C; Zhao Y; Chen L; Li Y; Yuan J; Chen Z; Yu J; Kong W; Chen T
    Front Oncol; 2022; 12():882786. PubMed ID: 35814414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
    Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
    Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiogenomic analysis based on lipid metabolism-related subset for non-invasive prediction for prognosis of renal clear cell carcinoma.
    He H; Xie Y; Song F; Feng Z; Rong P
    Eur J Radiol; 2024 Jun; 175():111433. PubMed ID: 38554673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions.
    Khaleel S; Katims A; Cumarasamy S; Rosenzweig S; Attalla K; Hakimi AA; Mehrazin R
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565216
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.